Envista Holdings Revenue 2018-2025 | NVST
Envista Holdings revenue from 2018 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Envista Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,511 |
| 2023 | $2,567 |
| 2022 | $2,569 |
| 2021 | $2,509 |
| 2020 | $1,929 |
| 2019 | $2,285 |
| 2018 | $2,845 |
| 2017 | $2,811 |
| Envista Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $617 |
| 2024-12-31 | $653 |
| 2024-09-30 | $601 |
| 2024-06-30 | $633 |
| 2024-03-31 | $624 |
| 2023-12-31 | $646 |
| 2023-09-30 | $631 |
| 2023-06-30 | $662 |
| 2023-03-31 | $627 |
| 2022-12-31 | $661 |
| 2022-09-30 | $631 |
| 2022-06-30 | $646 |
| 2022-03-31 | $631 |
| 2021-12-31 | $652 |
| 2021-09-30 | $607 |
| 2021-06-30 | $637 |
| 2021-03-31 | $613 |
| 2020-12-31 | $473 |
| 2020-09-30 | $547 |
| 2020-06-30 | $362 |
| 2020-03-31 | $547 |
| 2019-12-31 | $254 |
| 2019-09-30 | $659 |
| 2019-06-30 | $712 |
| 2019-03-31 | $660 |
| 2018-12-31 | |
| 2018-09-30 | $680 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.154B | $2.511B |
| Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.015B | 26.80 |
| ResMed (RMD) | United States | $36.786B | 27.63 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Agilent Technologies (A) | United States | $32.815B | 21.39 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Insulet (PODD) | United States | $21.238B | 83.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.517B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |